When did Estrella Immunopharma, Inc. report Q4 2024 earnings?

Estrella Immunopharma, Inc. (ESLA) reported Q4 2024 earnings on February 15, 2025 before market open.

What were Estrella Immunopharma, Inc.'s Q4 2024 revenue and EPS?

Estrella Immunopharma, Inc. reported eps of $-0.03 for Q4 2024.

EPS beat the consensus estimate of $-0.12 by $0.09.

Reported February 15, 2025 · Before market open

EPS-$0.03Beat by $0.09

EPS estimate-$0.12

Sep 2, 2026 (in a month)

EPS estimate-$0.09

Q4 2024-$0.03Beat by $0.09

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Estrella Immunopharma, Inc. report Q4 2024 earnings?: Estrella Immunopharma, Inc. (ESLA) reported Q4 2024 earnings on February 15, 2025 before market open.
What were Estrella Immunopharma, Inc.'s Q4 2024 revenue and EPS?: Estrella Immunopharma, Inc. reported eps of $-0.03 for Q4 2024.
Did Estrella Immunopharma, Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.12 by $0.09.